Interim report
Page 1
November 3, 2026 Listing Department Code: 531 335 BSE LIMITED P. J. Towers, Dalal Street, Mumbai–400 001 Listing Department Code: ZYDUSWELL NATIONAL STOCK EXCHANGE OF INDIA LIMITED Exchange Plaza, C/1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai–400 051 Sub: Outcome of Board Meeting Ref.: Unaudited financial results for the quarter and half year ended on September 30, 2026, pursuant to regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“the Listing Regulations”) Dear Sir / Madam, The Board of Directors at their meeting held today i.e. November 3, 2026, based on the recommendations of the Audit Committee, approved the unaudited financial results for the quarter and half year ended on September 30, 2026. In this regard, please find enclosed the following: 1. the unaudited financial results (standalone and consolidated) for the quarter and half year ended on September 30, 2026, reviewed by the Audit Committee and taken on record by the Board of Directors, today i.e. November 3, 2026 pursuant to regulation 33 of the Listing Regulations. 2. the Limited Review Reports of Mukesh M. Shah & Co., Chartered Accountants and the Statutory Auditors of the Company certifying the limited review of the unaudited financial results (standalone and consolidated) of the Company for the quarter ended and half year ended on September 30, 2026 pursuant to regulation 33 of the Listing Regulations.
Page 2
The Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed until Thursday, November 5, 2026, and shall re-open for trading on and from Friday, November 6, 2026 for all the Directors and Designated Persons of the Company. The Board meeting commenced at 11:00 a.m. and concluded at 12:20 p.m. Please find the same in order. Thanking you, Yours faithfully, For, ZYDUS WELLNESS LIMITED NANDISH P. JOSHI COMPANY SECRETARY & COMPLIANCE OFFICER Encl.: As above
Page 3
MUKESH M o SHAH & COo CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM STANDALONE FINANCIAL RESULTS To, The Board of Directors Zydus Wellness Limited Ahmedabad 1. We have reviewed the accompanying statement of Standalone Unaudited Financial Results of Zydus Wellness Limited ['the Company'], for the quarter and half year ended on September 30, 2026 ['the Statement'] attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations") . 2. This statement , which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting' ('Ind AS 34'), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit . Accordingly, we do not express an audit opinion. 4. Based on our review conducted as stated in paragraph 3 above, noth ing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. Place: Ahmedabad Date: November 3, 2026 +91-79-2647 2000 I contact@mmsco .in I www.mmsco.in For Mukesh M. Shah & Co Chartered Accountants Firm Regn. No. 106625W ~----=~ 7 th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015
Page 4
zyd~ Zydus Wellness Limited Registered office : Zydus corporate Park, scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Orcle, wellness Sarkhej-Gandhinagar Highway, Ahmedabad 382 481. ~, . • • ._ . ... ,, ...... ',.. Tel. No. (+91-79) 4804 0000 Website: www.zyduswellness.com, CIN: L15201Gl199'1PLC023490 Statement of Standalone Unaudited Financial Results for the Quarter and Half year ended September 30, 2026 , in Million Ouarter Ended Half Year Ended Year Ended September June September September Septembe r March Sr. No. Particulars 30, 2026 30, 2026 30, 2025 30, 2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Audited] 1 Income a Revenue from operations i Sales 1,525 1,353 1,451 2,878 2,754 5,284 ii Other operatirg income 143 177 109 320 215 537 Total Revenue from operations 1,668 1,530 1,560 3,198 2,969 5,821 b Other income 52 49 20 101 27 119 Total Income 1,720 1,579 1,580 3,299 2,996 5,940 2 Expenses a cost of matertals consumed 1,166 1,021 851 2,187 1,691 3,583 b Purchases of Stock-in-Trade 36 24 60 C Olanges in inventories of finished goods, work-in-progress and stock-in-trade (11) 3 61 (8) 33 59 d Employee benefits expense 126 153 134 279 308 568 e Finance costs 34 30 25 64 48 110 f Depreciation and amortisation expense 63 63 64 126 124 250 g Other expenses 185 211 245 396 514 825 h Net gain on foreign currency transactions (5) (12' (5) (13) (55) Total Expenses 1594 1 505 1 368 3 099 2 705 5 340 3 Profit before exceptional items and tax [1-2] 126 74 212 200 291 600 4 Exceptional items [Refer Note 4] - 97 - 97 112 5 Profit before tax [3-4] 126 74 115 200 194 488 6 Tax expense a Current tax (2) 2 51 - 59 40 b Deferred tax 12 17 r121 29 13 72 Total tax expense 10 19 39 29 72 112 7 Net Profit [5·6] 116 55 76 171 122 376 8 Other Comprehensive Income [OCI] a Items that will net be reclassified to profit or loss Re-measurement loss on post employment defined benefit plan (1) (3) (1) (5) (4) Income tax effect on above items - I - 1 1 Total Other Comprehensive Income [net of tax] 111 r2 (11 14) (3 9 Total Comprehensive Income [7 +8] 115 55 74 170 118 373 Paid-up equity share capital [Face Value ~ 2/· each] 636 636 636 636 636 636 Reserve exclucing Revaluation Reserve [i.e. Other equity] 39,690 Earnings per share [not annualised for the quarter] a Basic[~] 0.36 0.17 0.24 0.54 0.38 1.18 b Diluted m 0.36 0.17 0.24 0.54 0.38 1.18 Notes: 1. The above financial results were reviewed by the Aucit Committee and then approved by the Board of Directors at their meeting held on November 3, 2026. 2. The above financial results have been prepared in accordance with the COmpanies [Ind ian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securtties and Exchange Board of India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. 3. The Company operates in one segment, namely "Consumer Products". 4. Exceptional items comprise: Sr. Particulars , in Million No. Quarter Ended Half Year Ended Year Ended September June September September September March 30, 2026 30, 2026 30, 2025 30, 2026 30,2025 31, 2026 fUnauditedl runauditedl runauditedl runauditedl runauditedl fAuditedl i. Expenses related to liquidation of Naturell (India) Prtvate Limited [NIPL] with the company on a - - 97 - 97 97 going concern basis [Refer Note-SJ ii. One time impact of New Labour Codes - 15 Total - - 97 - 97 112 5. Pursuant to the voluntary liquidation process, as approved in extra ordinary general meeting of NIPL on July 1, 2025, effective from September 20, 2025, the Liquidator of NIPL has distrtbuted the Business Undertaking of NIPL on a going concern basis with the company . The entire business operations of NIPL have been consolidated with the company with effect from September 20, 2025. In view of the requirements of Appendix C to Ind AS 103 "'Business COmbination" preceding period figures have been restated from the date of acquisition of NIPL by the company (I.e. December 02, 2024). 6. Figures of previous reporting pertods have been regrouped/ reclassified wherever necessary to correspond with the figures of the current reporting pertod.
Page 5
Particulars ASSETS: Non-current assets: Property, plant and equipment capital work-in-progress Goodwill Other Intangible assets Financial assets: Investments Loans Other financial assets Deferred tax asset [net] Other non-current assets Assets for tax [net] Total Non-Current Assets Current assets: Inventories Financial assets: Investments Trade receivables cash and cash equivalents Bank balance other than cash and cash equivalents Loans Other current financial assets Other current assets Total Current Assets Total Assets EQUITY AND LIABILITIES: EQUITY: Equity share capital Other equity Total Equity UABILIT1ES: Non-current liabilities: Financial liabilities: Borrowings Lease liabilities Other financial liabilities Provisions Total Non-Current Liabilities Current liabilities: Financial liabilities: Borrowings Lease liabilities Trade payables: Due to micro and small enterprises Due to other than micro and small enterprises Other financial liabilities OthP.r current liabilities Provisions Total Current Liabilities Total Eauitv and Liabilities Standalone Statement of Assets and Liabilities ~ in Millions As at September 30 2026 IUnaudit:edl 440 13 1,133 2,561 36,716 401 3 160 44 31 41,502 377 249 697 17 4 40 210 87 1,681 43 183 636 39 478 40 114 1,710 13 9 68 1,800 500 4 102 467 154 22 20 1,269 43 183 March 31 2026 IAuditedl 403 49 1,133 2,660 36,712 382 3 189 78 16 41,625 283 275 71 4 273 116 86 1,108 42 733 636 39 690 40 326 1,290 13 9 65 1,377 500 4 85 345 46 30 20 1,030 42 733
Page 6
Standalone Statement of Cash Flows Particulars tr in Millions Half Year Ended September September 30 2026 30 2025 (Unaudited] (Unaudited] A. cash flow from operating activities: Profit before tax 200 194 Adjustments for: Depreciation and amortisation expense 126 124 Expected credit loss on trade receivables [net] 1 Net gain on sale of investments (1) (3) Interest income (17) (10) Interest expense, bank commission and charges 64 48 Effec:;t of foreign exchange movement on loan (4) (11) Provision for employee benefits 2 /5 Operating profit before working capital changes 371 337 Adjustments for: Increase in trade receivables (422) (22) [Increase)/ Decrease in other assets (63) 39 [Increase]/ Decrease in inventories (94) 2 Increase/[Decrease] in other liabilities 54 (274) Increase in trade payables 140 88 c.ash generated from operations (14) 170 Income taxes paid [net of refunds] us 123' Net cash from/ (used in) operating activities 129 147 B. cash flows from investing activities: Purchase of property, plant and equipment and other intangibles assets (32) (34) [including payment towards capital work-in-progress and capital advances] Proceeds from sale of Property, plant and equipment 6 3 Purchase of Non-current investment in other than subsidiary (4) (2) Repayment of loan by subsidiaries 250 40 Repayment of loan by other than related party 3 Loan given to subsidiaries . (137) Loan to other than related party (35) Purchase of Current Investments[net] (248) (11) Change in Bank balances (including fixed deposits) not considered as cash and cash . 63 equivalents Interest received 18 2 Net cash used in investing activities 1421 (76 C. Cash flows from financing activities: Proceeds from non-current borrowings 420 1,125 Repayment of non-current borrowings . (450) Current Borrowings [net - (repayment)/ taken] . (350) Repayment of lease liabilities (3) (1) Interest paid (18) (38) Dividend paid (3821 1381 Net cash from/ {used in) financing activities 17 (95 Net decrease in cash and cash equivalents [A+B+C] 1541 (24 cash and cash equivalents at the beginning of the period 71 42 cash and cash equivalents at the end of the period 17 18 Additional Information: Summarv of c.ash and cash eauivalents Bank Balance and Current investments: Particulars ~ in Million Asat September September 30, 2026 30, 2025 a. c.ash and cash equivalents 17 18 b. Bank balance other than cash and cash equivalents 4 5 c. Current Investments 249 80 Total 270 103 By Order of the Soard, For Zydus Wellness Limited, ¾~ l Dr. Sharvil P. Patel Place: Ahmedabad Olairman Date: November 3 2026 DIN: 00131995
Page 7
MUKES M. SHAH&CO . CHARTERED ACCOUNTANTS INDEPENDENT AUDITOR'S REVIEW REPORT ON REVIEW OF INTERIM CONSOLIDATED FINANCIAL RESULTS To, The Board of Directors, Zydus Wellness Limited 1. We have reviewed the accompanying statement of Consolidated unaudited financial results of Zydus Wellness Limited ['the Parent'] and its subsidiaries [the Parent and its subsidiaries together referred to as 'the Group'] for the quarter and half year ended on September 30, 2026 ['the Statement'] attached herewith, being submitted by the Parent pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, as amended ("the Listing Regulations") . 2. This statement, which is the responsibility of the Parent's Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34, 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2013 and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Listing Regulations, as amended, to the extent applicable. 4. The Statement includes the financial results of the following entities: a) Parent Company i) Zydus Wellness Limited b) Subsidiary Companies i) Zydus Wellness Products Limited ii) Liva Nutritions Limited iii) Alidac UK Limited iv) Comfort Click Softech Private Limited, India v) Comfort Click Limited, UK vi) Comfort Click Limited, Ireland vii) Comfort Click LLC, USA viii) Zydus Wellness International DMCC ix) Zydus Wellness (BO) Pvt Limited x) Naturell Inc. xi) Zydus Wellness General Trading DWC-LLC xii) Zydus Wellness Trading LLC xiii) Zydus Wellness (EU) Limited +91-79-2647 2000Icontact@mmsco.inIwww.mmsco.in 7 th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society, Nehru Nagar, Ahmedabad-380015
Page 8
MUKESH M .. SHAH & co. CHARTERED ACCOUNTANTS 5. Based on our review conducted and procedures performed as stated in Paragraph 3 above and based on the consideration of the review reports of the other auditors referred to in paragraph 6 below, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. 6. We did not review the interim financial information of § subsidiary Companies included in the consolidated unaudited financial results, whose interim financial information reflect [the figures reported below are before giving effect to consolidation adjustments] total assets of~ 66,650 million as at September 30, 2026, total income of~ 11,931 million and~ 26,786 million for the quarter and half year ended September 30, 2026 respectively, total net profit after tax of~ 134 million and~ 1,402 million for the quarter and half year ended September 30, 2026 respectively, total comprehensive income of~ 136 million and ~ 1,404 million for the quarter and half year ended September 30, 2026 respectively and net cash outflows of~ 674 million for the half year ended September 30, 2026, as considered in the Statement. This interim financial information has been reviewed by other auditors whose reports have been furnished to us by the Management and our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, is based solely on the reports of the other auditors and the procedures performed by us as stated in paragraph 3 above. Our conclusion on the Statement is not modified in respect of this matter . 7. The consolidated financial results also include the financial information of 4 subsidiary companies included in the consolidated unaudited financial results, whose interim financial information reflect [the figures reported below are before giving effect to consolidation adjustments] total assets of~ 26 million as at September 30, 2026, total income of~ 25million and~ 48 million for the quarter and half year ended September 30, 2026 respectively, total net loss after tax of~ 15 million and~ 20 million for the quarter and half year ended September 30, 2026 respectively, total comprehensive income of ~ (15) million and ~ (20) million for the quarter and half year ended September 30, 2026 respectively and net cash outflows of~ 2 million for the half year ended September 30, 2026, as considered in the Statement. No limited review of this financial information has been carried out by the auditors of the subsidiary; however, according to the information and explanations given to us by the Management, these interim financial results/ information are not material to the Group. Our conclusion on the Statement is not modified in respect of our reliance on the interim financial information as certified by the management. Place: Ahmedabad Date: November 3, 2026 +91-79-2647 2000 I contact@mmsco.in I www.mmsco.in I : For Mukesh M. Shah & Co. Chartered Accountants ~ .C:i'r.AH, C', irm Registration. No. 106625W er mbership No. 030190 7 th Floor, Heritage Chambers, Behind Bikanerwala Sweets, Near Azad Society , Nehru Nagar, Ahmedabad-380015
Page 9
: ·;:vd~ Zydus Wellness Limited Registered office : Zydus Corporate Park, Scheme No. 63, Survey No. 536 Khoraj (Gandhinagar), Near Vaishnodevi Circle, wi;;:lness Sarkhei·Gandhinaoar Hiqhwav. Ahmedabad 382 481. ' , > ·~, • .,. ,.., •'" Tel. No. (+91-79) 4804 0000 Website: www.zvduswellness.com ON: L15201GJ1994PLC023490 Statement of Consolidated Unaudited Financial Results for the Quarter and Half year ended September 30, 2026 Sr. Particulars , in Million No. Quarter Ended Half Year Ended Year Ended September June September September September March 30, 2026 30, 2026 JO, 2025 30, 2026 30, 2025 31, 2026 [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Unaudited] [Audited] 1 Income a Revenue from operations i Sales 11,227 14,299 6,429 25,526 15.006 39,400 ii Other operating income 39 71 76 110 108 210 Total Revenue from operations 11,266 14,370 6,505 25,636 15,114 39,610 b Other income 64 38 14 102 44 64 Total Income 11,330 14.408 6,519 25,738 15,158 39,674 2 Exoenses a Cost of materials consumed 3,159 3,076 2,605 6,235 5.277 12,123 b Purchases of stock-in-trade 1,320 1.426 436 2,746 948 4,164 C Changes in inventories of finished goods, work-in-progress and stock-in-trade (107) 432 22 325 716 (618) d Emolovee benefits exoense 888 968 664 1,856 1.346 3,130 e Finance costs 272 263 157 535 182 981 f Deoreciation and amortisation exoense 571 571 251 1,142 359 1.467 a Advertisement and oromotion exoense 1,972 2,612 935 4,584 2.260 6,459 h other exoenses 3,182 3.435 1,629 6,617 2.800 9,329. i Net [gain]/ loss on foreign currency transactions (3) 4 (16) 1 (19) (74) Total Exoenses 11254 12 787 6 683 24 041 13 869 36 961 3 Profit before exceotional items and tax r1-21 76 1,621 (164) 1,697 1,289 2.713 4 Exceptional items fRefer Note 51 - 342 342 408 5 Profit before tax 13-41 76 1,621 (506) 1,697 947 2.305 6 Tax expense a Current tax 146 401 89 547 97 306 b Deferred tax [Refer Note 61 C121l 31 (67\ 1901 99 27 Total tax exoense 25 432 22 457 196 333 7 Net Profit 15-61 51 1189 1528) 1240 751 1972 8 Other Comorehensive Income rOCil a Items that will not be reclassified to profit or loss Re-measurement loss on Post employment defined benefit plan 2 (4) 2 (6) (5) Income tax effect on above items Ill 1 {1' 1 1 Total 1 (3) 1 (5) (4) b Items that will be reclassified to orofit or loss Exchange differences on translation of financial statement of foreign operations 68 (110) (9) (42) (7) (42) Total 68 (110) (9) (421 (7) (42) Total other Comorehensive Income rnet oftaxl 69 (110) (12\ 1411 (12\ 146\ 9 Total Comorehensive Income r1+e1 120 1,079 (540) 1,199 739 1,926 10 Paid-up equity share capital [Face Value ~ 2/- each] 636 636 636 636 636 636 11 Reserve excluding Revaluation Reserve {Le. Other equity] 57,624 12 Earnings per share [not annualised for the quarter] a Basic fi{l 0.16 3.74 (1.66) 3.90 2.36 6.20 b Diluted [~) 0.16 3.74 (1.66) 3.90 2.36 6.20 Notes: I. The above financial results were reviewed by the Audit Committee and then approved by the Board of Directors at their meeting held on November 3, 2026. 2. The above financial results have been prepared in accordance with the Companies [Indian Accounting Standards] Rules, 2015 [Ind AS] as amended, prescribed under Section 133 of the Companies Act, 2013, read with relevant rules issued thereunder and in terms of Regulation 33 of Securities and Exchange Board of India [Listing Obligations and Disclosure Requirements] Regulations, 2015, as amended. 3. The Group operates in one segment, namely "Consumer Products". 4. Due to seasonality of some of the Group's products, Group's Revenues and Group's Profits are skewed in favour of the first and last quarters of the financial year. Hence the performance of these quarters is not representative and cannot be gene:·alised for other quarters. 5. Exceptional items comorise: Sr Particulars , in Million No Quarter Ended Half Year Ended Year Ended September lune September September September March 30, 2026 30, 2026 30, 2025 30, 2026 30, 2025 31, 2026 [Unaudited] [Unaudited) [Unaudited] [Unaudited) [Unaudited] [Audited] i. Expenses related to liquidation of Naturell (India) Private Limited [NIPL], a subsidiary of the 97 97 97 Company, on a going concern basis [Refer Note-8] ii. Expenses related to acquisition o_f Comfort Click Limited [CCL] [Refer Note-9] 245 245 245 iii. One time impact of New Labour Codes 66 Total - 342 - 342 408
Page 10
6. Toe financial results for the quarter ended September 30, 2025, the half year ended September 30, 2025 and the year ended March 31, 2026 include a net reversal of Minimum Alternate Tax (MAT) credit entitlement amounting to ,(21) million, U2S million and '354 million respectively. 7. As on September 30, 2026 the company has following subsidiaries: i. Zydus Wellness Prcxlucts Limited ii. Zydus Wellness (BD) Pvt Limited iii. Zydus Wellness International DMCC iv. Liva Nutritions Limited v. Naturell Inc vi. Alidac UK limited vii. Comfort Click limited, UK viii. Comfort Click Softech Private Limited ix. Comfort Click Limited, Ireland x. Comfort Click LLC xi. Zydus Wellness General Trading DWC-UC xii. Zydus Wellness Trading L.L.C. xiii. Zydus Wellness (EU) limited 8. On July 1, 2025 a special resolution was passed in the extra ordinary general meeting of NIPL to approve the voluntarily liquidation of NIPL on a going concern basis. Pursuant to the same, the Liquidator of NIPL, has distributed the entire busine.55 undertaking of NIPL on a going concern basis to the Company on and with effect from September 20, 2025. The entire business operations of NIPL stands consolidated with the Company with .effect from September 20, 2025. The Company.has given effect of the liquidation as per the requirements of Appendix C to Ind AS 103 "Busin~ Combination". 9. Pursuant to the Share Purchase Agreement ["SPA"] entered into by Alidac UK Limited [Alkfac], a wholly owned subsidiary of the Company, on August 29, 2025, to acquire Comfort Clkk Limited [CCL], Alidac has successfully completed the acquisition cJ CCL on August 29, 2025. Alidac acquired 100% outstanding ordinary shares of Class A and Class B, 71.43%, a non-controlling ordinary shares of Class C and 66.67% of non-controlling ordinary shares of Class D of CCL. The cost of acquisition is GBP 239 million, along with a profit-ticker payment of GBP 2.64 million, in accordance with the terms of SPA. The results include the operations of CCL effective from August 29, 2025. 10. Figures of previous reporting periods have been regrouped/ reclassified wherever necessary to correspond with the figures of the current reporting period. 11. The detailed standalone results are available on the Company's website: www.zyduswellness.com, on the website of BSE [www.bseindia.com] and on the website of NSE [www .nseindia.com]. The summarised standalone financial results of the Company are as below: Particulars , in Million Sr. Ouarter Ended Half Year Ended Year Ended No September lune September September September March 30, 2026 30, 2026 30 2025 30, 2026 30, 2025 31, 2026 (Unaudited) (Unaudited) (Unaudited] (Unaudited) [Unaudited] (Audited) i. Revenue from operations 1,668 1,530 1,560 3,198 2,969 5,821 ii. Profit before exceptional items and tax 126 74 212 200 291 600 iii. Profit after tax 116 55 76 171 122 376 iv. Other Comprehensive Income (1) (2) (1) (4) (3) v. Total romnrehenc:ive Income 115 55 74 170 118 373
Page 11
Particulars ASSETS: Non-current assets: Property, plant and equipment (apltal work-in-progress Goodwill Other intangible assets Financial assets: Investments Loans Other financial assets Deferred ta,c: asset [net) Other non"'urrent assets Assets for tax [net] Total Non-Current Assets Current assets:. Inventories Rnancial assets: Investments Trade receivables cash and cash equivalents Bank balance ether than cash and cash equivalents Loans Other current financial assets Other current assets Total Current Assets Total Assets EQUITY AND UABILITlES : EQUITY: EQuitv share capital Other equity Total Equity UABILITTES : Non-current liabilities: Financial liabilities: Borrowings Lease liabilities Other financial liabi!ities Provisions Deferred Tax Liabilities Total Non-Current Liabilities Current liabilities: Financial liabilities: Borrowings Lease liabilities Trade payables: Due to micro and small enterprises Due to other than micro and small enterprises Other financial liabilitiP.S Other current liabilities Provisions Current Tax Liabilities (Net) Total Current Liabilities Total Eauitv and Liabilities Consolidated Statement of Assets and Liabilities , in Million Asat September March ,n '"" " '"'" runauditedl rAudit edl 4,286 3,153 184 231 49,403 49,419. 32,329 33,387 13 9 17 2 61 60 1,046 1,179 1, 183 1,870 300 101 88,822 89,411 7,475 7,638 2,213 42 2,843 3,838 367 1,106 40 5 46 35 1,050 459 665 544 14 699 13 667 1 03 521 1 03 078 636 636 58441 57 624 59077 58 260 30,003 30,349 106 121 564 449 316 294 6 080 6 320 37,069 37,533 1,520 1,515 44 43 318 334 4,294 4,280 257 302 396 418 400 392 146 1 7,375 7,285 1 03 521 1 03 078
Page 12
Consolidated Statement of Cash Flows Particulars , In Million Half Year Ended September September ,n '"" ,n '"'" [Unaudited] [Unaudited] A. cash flow from operating activities: Profit before tax 1,697 947 Adjustments for: Depreciation and amortisation expense 1,142 359 Net loss on disposal of property, plant and equipment I Expected credit loss on trade receivables [netl 15 Net gain on sale of investments (16) (31) Interest income (79) (8) Interest expense, bank commission and charges 535 182 Exchange rate nuctuation and other related adjustments arising on consofidation (18) (!) Amortisation of deferred revenue on Government grants (1) (2) Provision for employee benefits 36 28 Operating profit bef°'e working capital changes 3,311 - 1,475 Adjustments for: Decrease in trade receivables 1,025 1,553 Increase in other assets (679) (238) Decrease in inventories 159 759 Increase/ [Decrease] in other liabilities 49 (295) Decrease In trade payables 1143' (21291 cash generated from operations 3,722 1,125 Income taxes paid [net of refunds] 1601' 1194\ Net cash from operating activities 3,121 931 B. cash flows from investing activities: Purchase of property, plant and equipment and other intangibles assets (450) (696) [Including payment towards ca pit.al work-in•progress and capital advances] Purchase of Non-<urrent investment in subsidiary - (28,180) Purchase of Non-current investment in other than subsidiary (4) (2) Proceeds from sale of property, plant and equipment 9 4 Repayment of loan by other than related party 9 2 Loan given to other than related party (35) Purchase of current investments[net] (2,155) 122 Proceeds from non-current fixed deposit [net] - (2) Change in Bank balances (including fixed deposits} not considered as cash and cash eQuivalents (35) 66 Interest received 79 8 Net cash used in investing activities (2,582) (28,678) C. Cash flows from financing activities: Proceeds from non-current borrowings 40 28,811 Repayment of Non-{urrent Borrowing (331) Current Borrowings [net- (repayment)/ taken] - (350) Repayment of lease liabilities (31) (10) Interest paid (574) (58) Dividend paid 1382' 1381' Net cash from/ (used in) financing actlvitie5 (12781 28 012 Net increase/ [decrease] in cash and cash equivalents [A+B+CJ 1739 265 cash and cash equivalents at the beginning of the period 1,106 667 cash and cash equivalents of the acquired subsidiary - 277 cash and cash Pnuivalents at the end of the nerlod 367 I 209 Additional Information: Summarv of Cash and cash PnUiva1ents Bank Balance and Current investments: Particulars , In Million Asat September September ,n ,n,~ ,n ,.,. a. Cash and cash equivalents 367 1,209 b. Bank balance other than cash and cash equivalents 40 6 c. Current Investments 2 213 266 Total 2 620 1481 ~Y Order of the Board, For Zydus Wellness limited, Place: Ahmedabad ,t~ Date: November 3 ,2026 Chairman nJN: 001 l 1 OOC b